Variantyx Funding & Investors
Framingham, MA
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.
variantyx.comTotal Amount Raised: $136,500,000
Variantyx Funding Rounds
Series D
$36,000,000
Series D Investors
New Era Capital PartnersPeregrine VenturesRobert Bosch Venture CapitalPitango Venture CapitalDebt Financing
$20,000,000
Debt Financing Investors
Kreos CapitalSeries C
$41,500,000
Series C Investors
New Era Capital PartnersRobert Bosch Venture CapitalPeregrine Ventures20/20 Healthcare PartnersPitango Venture CapitalSeries C
$6,000,000
Series C Investors
Robert Bosch Venture CapitalSeries C
$20,000,000
Series C Investors
Global health sciences venture fundIBM VenturesPitango Venture CapitalNew Era Capital Partners20/20 Healthcare PartnersSeries B
$10,000,000
Series B Investors
Pitango Venture CapitalNew Era Capital PartnersSeries A
$3,000,000
Funding info provided by Diffbot.